ATM-Ranking-2021
Boehringer Ingelheim climbs two places. New early-stage research projects for disease areas relevant to low-to-middle income countries not reflected.
Search
Animal Health Partnering Interests Immunology & Inflammation May 2024 CORP
Immunology SPESOLIMAB GPP infographic
Immunology SPESOLIMAB IL-36 infographic_
Immunology Flyer Q1 2021.pdf
Immunology_Inflammation.pdf
Immunology_Flyer_BIO-2021.pdf
Partnering_In_IMMUNOLOGY_0.pdf
Partnering in Immunology & Inflammation MAY 2024 CORP_0.pdf
Immunology_Partnering_Interests_2018-12.pdf
Partnering in Immunology & Resp HP OCTOBER 2024 CORP.pdf
Innovation in medicinal chemistry
Darryl McConnell, Research Site Head, Austria and Jürgen Mack, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
RE-LY-trial-publication-10-year-anniversary
Boehringer Ingelheim recognises the contribution made in the decade since the RE-LY® trial publication by patients, HCPs and researchers
Cooperation with Google Quantum AI
Advancing green chemistry for more sustainable medicines
By applying the principles of eco-design and green chemistry, we developed an innovative manufacturing process with reduced environmental footprint.
Inauguration of new global center for veterinary vaccine R&D
Inauguration of a new global hi-tech centre for biological research and development in Lyon.
Sustainable medicines that help minimize environmental impact
How we collaborate with renowned experts to lead the way in reducing solvent waste, as part of our efforts to embed sustainability into our core business.
Our_Inflammatory_Disease_Research.pdf
Research Beyond Borders Infographic
Clinical_Research_2015.pdf
Respiratory Research and Development Timeline.pdf
R&D - Transforming tomorrow
Manami Tsutsumi, Senior Associate Director in Research & Development describes what it's like working on the cutting edge of pharmaceutical development.
Careers: Winning with people
Our employees are the foundation of our innovative strength. We continue to put people first in everything we do and support our employees in the key moments of their careers.
Horses
Horses
Protein Degraders in Cancer
Boehringer Ingelheim scientists and their partners are exploring how protein degraders could bring so-called undruggable cancer targets within reach